Dow makes another high after spending the day in negative territory

Published 27-FEB-2017 11:23 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

While the Dow hit another all-time high on Friday, it was a slim gain of only 11 points after the index had spent the majority of the day in negative territory, only to be pushed to another record in the last 30 minutes of trading.

Consequently, this shouldn’t be interpreted as a rally that will necessarily see the last fortnight’s record-breaking run continue into the coming week. Of importance is the fact that financial stocks came under pressure, as this has been an extremely well supported sector, and because of its large index weighting it has been instrumental in driving the Dow to record-breaking highs.

There appears to be a hint of scepticism re-emerging. The run-in financials was mainly due to confidence in President Trump loosening regulatory policies in that sector. As questions begin to be asked whether substantial tax reform will materialise, it seems that faith in financial sector reforms may now be waning as investors pause for proof.

The NASDAQ also spent most of the day in negative territory before eking out a gain of 10 points, representing an increase of less than 0.2%.

The negative sentiment rubbed off on European markets as they closed prior to the late rally in the US. Similar sectors were sold down with financial stocks particularly taking a hit.

The FTSE 100 shed nearly 30 points or 0.4% to close at 7,243 points.

The DAX plunged 1.2%, closing at 11,804 points, while the Paris CAC 40 came off 1% to close at 4,845 points.

On the commodities front, oil pullback to US$54 per barrel.

Gold increased 0.5% to US$1258 per ounce, responding positively to market volatility.

There was good support for base metals as nickel rallied more than 2% to close at US$4.90 per pound, recovering some of the ground lost in the mid-week sell-off.

Zinc rallied approximately 1.7% to US$1.28 per pound, while lead was up approximately 1% to US$1.02 per pound.

Copper joined in the rally, finishing at US$2.67 per pound.

The Australian dollar came off substantially to finish the week at US$0.767.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free